A polymethoxylated flavone, composition and pharmaceutical preparation thereof for preventing or treating non-alcoholic fatty liver
A technology of polymethoxyflavone and heptamethoxyflavone, applied in the field of medicine, can solve problems such as unsatisfactory effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment Construction
[0016] The technical solutions of the present invention will be described in detail below in conjunction with the accompanying drawings and embodiments.
[0017] experimental method:
[0018] 1. Establishment of animal models
[0019] Take 60 C57BL / 6 male mice, weighing 18-20 g, aged 6 weeks. After one week of adaptation, the mice were randomly divided into: normal diet group (Normal chow diet, NCD), high fat diet group (High fat diet, HFD), lovastatin group (Lovastatin, LOV), 3,5,6,7, 8,3',4'-heptamethoxyflavone low-dose group (HMF-L) and 3,5,6,7,8,3',4'-heptamethoxyflavone high-dose group (HMF-H ), and the other groups except the normal diet group adopted a high-fat diet. HFD feed formula is: 1.25% cholesterol, 20% lard, 5% sucrose, 0.5% cholic acid, vitamins adjusted to normal levels.
[0020] 2. Dosage and administration method: In the HFD induction experiment, mice were administered by intragastric administration. Modeling began to administer drugs, and NCD and HFD w...
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com